Tara Henderson, MD, MPH, specializes in the diagnosis and medical treatment of patients with pediatric cancers. She has a particular interest in the care of childhood cancer survivors.
Dr. Henderson's research focuses on the development of and screening for second cancers in childhood cancer survivors. Although treatment of childhood malignancies has become increasingly successful, with a current overall cure rate approaching 80 percent, with it comes the long-term toxic late effects of chemotherapy and radiation during critical stages of development, including second cancers and damage to vital organ systems. Dr. Henderson is interested in the characterization of second cancers and those susceptible, so that early and appropriate screening regimens can be developed.
Dr. Henderson's research focuses on the development of and screening for second cancers in childhood cancer survivors. Although treatment of childhood malignancies has become increasingly successful, with a current overall cure rate approaching 80 percent, with it comes the long-term toxic late effects of chemotherapy and radiation during critical stages of development, including second cancers and damage to vital organ systems. Dr. Henderson is interested in the characterization of second cancers and those susceptible, so that early and appropriate screening regimens can be developed.
Areas of Expertise
- Childhood Cancer Survivors
- Adolescent and Young Adult (AYA) Cancer Care
- Lymphoma
Board Certifications
- Pediatric Hematology and Oncology
- Pediatrics
Memberships & Medical Societies
- New England Retinoblastoma Support Group
- American Academy of Pediatrics
Practicing Since
- 1999
Languages Spoken
- English
Medical Education
- University of Chicago Pritzker School of Medicine
Residency
- Johns Hopkins Medicine
Fellowship
- Children's Hospital Boston
Other Grad Education
- Harvard University,MPH
News & Research
View Published Papers- Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
- Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
- Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
- Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
- ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study
- Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
- Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- Intervention For AYAS With Cancer Risk Syndromes
- Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
- Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
- Childhood Cancer Survivor Study
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Neuropsychological and Behavioral Testing in Younger Patients With Cancer
- Aetna HMO (specialists only)
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Aetna Better Health *see insurance page
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- Aetna Medicare Advantage HMO & PPO
- BCBS Medicare Advantage HMO & PPO
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- United Choice HMO (specialists only)
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
Comer Children's Hospital - Hyde Park
Request an Appointment at Comer Children's Hospital - Hyde Park
To Refer a Patient
Refer a Patient
